Summer Appreciation Sales Offers 12% Off All Products
NEW YORK, Aug. 15, 2025 /PRNewswire/ -- BestQool , a pioneer manufacturer of home-use red light therapy...
TUY HOA, Vietnam, Aug. 15, 2025 /PRNewswire/ -- Discover a tranquil retreat infused with modern luxuries at TUI BLUE Tuy Hoa, a wellness-focused resort hotel....
NANJING, China, Aug. 15, 2025 /PRNewswire/ -- Tuniu Corporation (NASDAQ: TOUR) ("Tuniu" or the "Company"), a leading online leisure travel company in China, today announced...
Global brand-wide initiative honors Jimmy Buffett's legacy through community give-back events benefiting local and global causes
ORLANDO, Fla., Aug. 14, 2025 /PRNewswire/ -- Today, Margaritaville...
The Functional Foods Market is experiencing robust expansion, driven by rising consumer focus on health, wellness, and preventive nutrition. Growing demand for nutrient-enriched products,...
The Functional Foods Market is experiencing robust expansion, driven by rising consumer focus on health, wellness, and preventive nutrition. Growing demand for nutrient-enriched products,...
Three Year Collaboration with the American Historical Association, the Modern Language Association, and the Society of Biblical Literature Aims to Identify and Introduce New...
ROAD TOWN, British Virgin Islands, Aug. 13, 2025 (GLOBE NEWSWIRE) -- LYNO AI is fast approaching its Early Bird cap as the AI-powered cross-chain arbitrage token continues to gain momentum. The presale phase offers LYNO tokens at $0.050 per token with 16 million tokens available in this stage.
Pratteln, Switzerland, 13 August, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Gen İlaç ve Sağlık Ürünleri San. ve Tic. A.Ş. (GEN) for the distribution and promotion of AGAMREE® (vamorolone) in Türkiye for the treatment of Duchenne muscular dystrophy (DMD) in patients four years of age and older.
TORONTO, Aug. 12, 2025 (GLOBE NEWSWIRE) -- (TSX: GDV, GDV.PR.A) Global Dividend Growth Split Corp. (the “Fund”) is pleased to announce that the board of directors of the Fund has approved an extension of the maturity date of the class A shares (the “Class A Shares”) and preferred shares (the “Preferred Shares”) of the Fund. The current maturity date of June 30, 2026 will be extended for an additional term of approximately 5 years to June 27, 2031. The Preferred Share dividend rate for the extended term will be announced at least 60 days prior to the current June 30, 2026 maturity date and will be based on market yields for preferred shares with similar terms at that time. The term extension allows Class A shareholders to continue their investment with an attractive distribution rate of 10.7% based on the August 11, 2025 closing price, and the opportunity for capital appreciation.(1) The extension of the term of the Fund is not a taxable event and enables shareholders to defer potential capital gains tax liability that would have otherwise been realized on redemption of Class A Shares or Preferred Shares at the end of the term, until such time that shares are disposed of by shareholders.